Atlas Trials

Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines

Clinical trial NCT00480454 · COMPLETED

Trial details

NCT number
NCT00480454
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
TB
Start date
2006-10-01
Primary completion
2009-12-01
Enrollment
214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.